These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20732072)

  • 1. Comments on the scientific validation and regulatory acceptance of in vitro toxicity tests.
    Balls M; Clothier RH
    Toxicol In Vitro; 1991; 5(5-6):535-8. PubMed ID: 20732072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why modification of the LD50 test will not be enough.
    Balls M
    Lab Anim; 1991 Jul; 25(3):198-206. PubMed ID: 1921314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Validation and Technology Transfer Committee of the Johns Hopkins Center for Alternatives to Animal Testing. Framework for validation and implementation of in vitro toxicity tests.
    Goldberg AM; Frazier JM; Brusick D; Dickens MS; Flint O; Gettings SD; Hill RN; Lipnick RL; Renskers KJ; Bradlaw JA
    Xenobiotica; 1993 May; 23(5):563-72. PubMed ID: 8342302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OECD ist accepting test guidelines for validated in vitro toxicity tests in 1996.
    Spielmann H; Reinhardt C
    ALTEX; 1996; 13(4):167-174. PubMed ID: 11178458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of animal procedures: alternatives in research, education and testing.
    Balls M
    Lab Anim; 1994 Jul; 28(3):193-211. PubMed ID: 7967458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
    Spielmann H; Liebsch M
    Toxicol In Vitro; 2001; 15(4-5):585-90. PubMed ID: 11566595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
    Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Third FRAME Toxicity Committee: working toward greater implementation of alternatives in toxicity testing.
    Combes RD; Balls M; Bansil L; Barratt M; Bell D; Botham P; Broadhead C; Clothier R; George E; Fentem J; Jackson M; Indans I; Loizou G; Navaratnam V; Pentreath V; Phillips B; Stemplewski H; Stewart J
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():635-42. PubMed ID: 23581152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of in vitro toxicology studies in risk assessment.
    Murthy B
    ALTEX; 2007; 24(3):174-7. PubMed ID: 17891324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaboration between ZEBET, FRAME, and ECVAM: FRAME's contribution to establishing the Three Rs in Europe.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():23-7. PubMed ID: 20105007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRAME Annual Lecture. International co-operation: an essential requirement for replacing animal toxicity tests.
    Spielmann H
    Altern Lab Anim; 2001; 29(6):637-46; discussion 647-8. PubMed ID: 11709040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and regulatory acceptance of new carcinogenicity tests.
    Spielmann H
    Toxicol Pathol; 2003; 31(1):54-9. PubMed ID: 12597449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framework for validation and implementation of in vitro toxicity tests.
    Goldberg AM; Frazier JM; Brusick D; Dickens MS; Flint O; Gettings SD; Hill RN; Lipnick RL; Renskers KJ; Bradlaw JA
    In Vitro Cell Dev Biol Anim; 1993 Sep; 29A(9):688-92. PubMed ID: 8407711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation: A highly charged concept.
    Koëter HB
    Toxicol In Vitro; 1995 Dec; 9(6):851-6. PubMed ID: 20650166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
    Schechtman LM
    ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workshop overview: scientific and regulatory challenges for the reduction, refinement, and replacement of animals in toxicity testing.
    Purchase IF; Botham PA; Bruner LH; Flint OP; Frazier JM; Stokes WS
    Toxicol Sci; 1998 Jun; 43(2):86-101. PubMed ID: 9710950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERGATT/ECVAM Workshop on Acceptance of Validated Alternative Methods: Amden III.
    Spielmann H; Liebsch M; Reinhardt C
    ALTEX; 1998; 15(1):18-22. PubMed ID: 11208263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflections on the progress towards non-animal methods for acute toxicity testing of chemicals.
    Prior H; Casey W; Kimber I; Whelan M; Sewell F
    Regul Toxicol Pharmacol; 2019 Mar; 102():30-33. PubMed ID: 30578838
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.